Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sernova Biotherapeutics (SEOVF)

Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Sernova Biotherapeutics Announces Warrant Amendments

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company...

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused...

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

ELDN : 2.19 (-1.35%)
SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Appoints Jonathan Rigby as Interim Chair

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Chair of Sernova Biotherapeutics Resigns

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

SVA.TO : 0.1400 (-3.45%)
SEOVF : 0.1026 (-0.68%)

Barchart Exclusives

NVDA Earnings, Tariffs and Other Key Things to Watch this Week
Markets enter a critical week dominated by Wednesday's Nvidia earnings and escalating geopolitical tensions as rising U.S.-Iran hostilities push oil prices higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar